Breast Cancer Screening Among 26 Medicaid Measures

David Rosenfeld | | Radiology Business | Business Intelligence
Breast cancer screening made the list of 26 Medicaid quality measures that states may begin reporting to the Centers for Medicare and Medicaid Services next year. Measurements excluded other forms of diagnostic imaging. CMS developed the measures along with the Agency for Healthcare Research and Quality and feedback through public comments. While reporting is voluntary, the agency expects states to take advantage of opportunities to improve. Those that report should be better able to measure their own performance and deliver better care. “These core set measures will support HHS and its State partners in developing a quality-driven, evidence-based, national system for measuring the quality of health care provided to Medicaid-eligible adults,” according to the recent notice in the federal register. The measurements were developed as part of the Affordable Care Act and will be reported by states as well as insurance companies that contract to manage Medicaid enrollees.

David Rosenfeld

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.